Origin Materials, Inc.

NasdaqCM:ORGN Stock Report

Market Cap: US$177.6m

Origin Materials Valuation

Is ORGN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ORGN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ORGN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ORGN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ORGN?

Key metric: As ORGN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ORGN. This is calculated by dividing ORGN's market cap by their current revenue.
What is ORGN's PS Ratio?
PS Ratio5.1x
SalesUS$35.12m
Market CapUS$177.63m

Price to Sales Ratio vs Peers

How does ORGN's PS Ratio compare to its peers?

The above table shows the PS ratio for ORGN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.4x
CMT Core Molding Technologies
0.5x-6.6%US$151.4m
SIRE Sisecam Resources
0.7xn/aUS$511.9m
TSE Trinseo
0.04x5.0%US$125.7m
MATV Mativ Holdings
0.4x1.7%US$716.7m
ORGN Origin Materials
5.1x46.9%US$177.6m

Price-To-Sales vs Peers: ORGN is expensive based on its Price-To-Sales Ratio (5.1x) compared to the peer average (0.3x).

Price to Sales Ratio vs Industry

How does ORGN's PS Ratio compare vs other companies in the US Chemicals Industry?

10 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.04x5.0%US$125.68m
ALTO Alto Ingredients
0.1x3.1%US$108.84m
BON Bon Natural Life
0.2xn/aUS$6.23m
ABLT American Biltrite
0.02xn/aUS$2.91m
ORGN 5.1xIndustry Avg. 1.4xNo. of Companies17PS01.22.43.64.86+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ORGN is expensive based on its Price-To-Sales Ratio (5.1x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is ORGN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ORGN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.1x
Fair PS Ratio3.4x

Price-To-Sales vs Fair Ratio: ORGN is expensive based on its Price-To-Sales Ratio (5.1x) compared to the estimated Fair Price-To-Sales Ratio (3.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Ecora Resources

UK£162.5m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.82

7D

-4.5%

1Y

-28.7%

Allied Gold

CA$1.1b

Explores for and produces mineral deposits in Africa.

AAUC.F

CA$2.47

7D

16.0%

1Y

-18.0%

CMOC Group

HK$159.9b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.77

7D

-2.2%

1Y

29.7%